7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

PMV Pharmaceuticals, Inc
(NASDAQ:PMVP) 

PMVP stock logo

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and r...

Full Time Employees: 39
CEO: David H. Mack  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
PMV Pharmaceuticals Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0144.51289.02433.53578.04722.54867.051,011.56
PMV Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.72-1.48-1.23-0.98-0.74-0.49-0.250
PMV Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.88-1.62-1.35-1.08-0.81-0.54-0.27-0
PMV Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.871.742.613.484.355.226.09
PMV Pharmaceuticals P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 08.4716.9425.4133.8842.3550.8159.28
PMV Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,305.5-1,119-932.5-746-559.5-373-186.50
PMV Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 056.99113.97170.96227.94284.93341.91398.9
No extra charts and metrics for this ticker.